加拿大眼科设备市场 - 增长、趋势、COVID-19 影响和预测(2022 - 2027 年)

加拿大眼科药物和器械市场按产品(药物和器械)和疾病细分

市场快照

Canada Ophthalmic Drugs & Devices  Devices & Drugs Market
Study Period: 2018 - 2026
Base Year: 2021
CAGR: 2 %

Need a report that reflects how COVID-19 has impacted this market and its growth?

市场概况

在预测期内,加拿大眼科药物和器械市场预计将以 2% 的复合年增长率增长。推动市场增长的某些因素包括人口结构变化、眼病流行的影响、眼科领域的技术进步以及老年人口的增加。预计人口老龄化会给所有医疗保健领域带来负担,眼科医生向老年人提供大约 90% 的基于手术的服务。在加拿大,视力障碍的主要原因是青光眼、糖尿病视网膜病变、退行性近视、年龄相关性黄斑变性和白内障。此外,根据全球健康数据交换,2018 年老年性黄斑变性的患病率约为 18,644 人。预计 2019 年这一数字将增加 19,252 人。因此,

Scope of the report

As per the scope of the report, ophthalmology devices are the equipment that are used for the diagnosis and treatment of various ophthalmic diseases, such as cataract, glaucoma, and refractive errors. Ophthalmic drugs are used to treat eye infections and some of the above-mentioned diseases. The drugs covered in the report are glaucoma drugs, retinal disorder drugs, dry eye disease drugs, drugs for infections, and other drugs

By Product
Devices
Surgical Devices
Intraocular Lenses
Ophthalmic Lasers
Other Surgical Devices
Diagnostic Devices
Drugs
Glaucoma Drugs
Retinal Disorder Drugs
Dry Eye Drugs
Allergic Conjunctivitis and Inflammation Drugs
Other Drugs
By Disease
Glaucoma
Cataract
Age-Related Macular Degeneration
Inflammatory Diseases
Refractive Disorders
Other Diseases

Report scope can be customized per your requirements. Click here.

主要市场趋势

白内障细分市场预计将在预测年份显示出更好的增长

根据疾病,市场细分为青光眼、白内障、老年性黄斑变性、炎症性疾病、屈光障碍等疾病。根据全球健康数据交换,估计 2018 年加拿大的白内障患病率为 193,707 人。2019 年进一步增加了 197,442 人。白内障手术仍然是帮助白内障患者恢复视力的最有效方法。因此,随着日本眼病负担的增加,预计市场将在预测期内增长。

key trend canada drug.png

竞争格局

加拿大眼科药物和器械市场竞争分散,由几个主要参与者组成。就市场份额而言,目前很少有主要参与者占据市场主导地位。目前主导市场的一些公司是 Alcon Inc.、Bausch Health Companies Inc.、Carl Zeiss Meditec AG、Essilor International SA、Johnson & Johnson、Nidek Co. Ltd、Topcon Corporation、Ziemer Group AG

Table of Contents

  1. 1. INTRODUCTION

    1. 1.1 Study Assumptions

    2. 1.2 Scope of the Study

  2. 2. RESEARCH METHODOLOGY

  3. 3. EXECUTIVE SUMMARY

  4. 4. MARKET DYNAMICS

    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Demographic Shift and Impact of Prevalence of Eye Disease

      2. 4.2.2 Technological Advancements in the Field of Ophthalmology

    3. 4.3 Market Restraints

      1. 4.3.1 Higher Cost of the Ophthalmic Devices and Treatment

    4. 4.4 Porter's Five Force Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry

  5. 5. MARKET SEGMENTATION

    1. 5.1 By Product

      1. 5.1.1 Devices

        1. 5.1.1.1 Surgical Devices

          1. 5.1.1.1.1 Intraocular Lenses

          2. 5.1.1.1.2 Ophthalmic Lasers

          3. 5.1.1.1.3 Other Surgical Devices

        2. 5.1.1.2 Diagnostic Devices

      2. 5.1.2 Drugs

        1. 5.1.2.1 Glaucoma Drugs

        2. 5.1.2.2 Retinal Disorder Drugs

        3. 5.1.2.3 Dry Eye Drugs

        4. 5.1.2.4 Allergic Conjunctivitis and Inflammation Drugs

        5. 5.1.2.5 Other Drugs

    2. 5.2 By Disease

      1. 5.2.1 Glaucoma

      2. 5.2.2 Cataract

      3. 5.2.3 Age-Related Macular Degeneration

      4. 5.2.4 Inflammatory Diseases

      5. 5.2.5 Refractive Disorders

      6. 5.2.6 Other Diseases

  6. 6. COMPETITIVE LANDSCAPE

    1. 6.1 Company Profiles

      1. 6.1.1 Alcon Inc.

      2. 6.1.2 Bausch Health Companies Inc.

      3. 6.1.3 Carl Zeiss Meditec AG

      4. 6.1.4 Essilor International SA

      5. 6.1.5 Johnson & Johnson

      6. 6.1.6 Nidek Co. Ltd

      7. 6.1.7 Topcon Corporation

      8. 6.1.8 Ziemer Group AG

    2. *List Not Exhaustive
  7. 7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Competitive Landscape covers- Business Overview, Financials, Products and Strategies, and Recent Developments

You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

The Canada Ophthalmology Drugs & Devices Market market is studied from 2018 - 2026.

The Canada Ophthalmology Drugs & Devices Market is growing at a CAGR of 2% over the next 5 years.

Alcon Inc., Bausch Health Companies Inc, Carl Zeiss Meditec AG, Johnson & Johnson, Nidek Co. Ltd are the major companies operating in Canada Ophthalmology Drugs & Devices Market.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!